Comparison of Endometrial Protein Profile in Spontaneous Versus Stimulated Menstrual Cycles in Poor Responders
NCT06804174 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2025-02-03
Summary
Evaluation of endometrial protein profile in spontaneous and stimulated menstrual cycles
Conditions
- Proteome
Interventions
- OTHER
-
use of gonadotropins
Comparison of endometrial proteome during the window of implantation between stimulated and spontaneous cycles.
Sponsors & Collaborators
-
Slovenian Research Agency (ARRS)
collaborator UNKNOWN -
University Medical Centre Ljubljana
lead OTHER
Principal Investigators
-
Eda Prof. Vrtačnik bokal, MD, PhD · Division of Obstetrics and Gynecology, University Medical Centre Ljubljana
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 43 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-09-01
- Primary Completion
- 2024-06-30
- Completion
- 2024-09-01
Countries
- Slovenia
Study Locations
More Related Trials
-
Biomarkers in Endometriosis
NCT04591548 ·Status: COMPLETED
-
Medroxyprogesterone Acetate vs LNG-IUS in Early-stage Endometrioid Carcinoma and Atypical Hyperplasia Patients
NCT05565573 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Correlation Between Serum Progesterone Level And Primary Dysmenorrhea
NCT06359457 ·Status: COMPLETED
-
Harnessing the Disease Signatures From Endometrium and Menstrual Blood to Identify Avenues for the Treatment of Chronic Conditions Such as Endometriosis and Related Pathologies: This is an Observational Study Aimed at Shedding Light on Women's Health
NCT06990971 ·Status: NOT_YET_RECRUITING
-
Megestrol Acetate Plus LNG-IUS in Young Women With Early Endometrial Cancer
NCT03241914 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Continuous Versus Cyclic Oral Contraceptives for Endometriosis
NCT02237131 ·Status: UNKNOWN ·Phase: PHASE4
-
Endometrial Receptivity Profile in Patients With Endometrial Proliferation Defects
NCT02406690 ·Status: COMPLETED
-
A Study of Progenta (CDB-4124) in Pre-menopausal Women With Symptomatic Leiomyomata
NCT01069094 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Gene Expression Analysis of the Endometrium After Endometrial Biopsy in Fertile Women
NCT02219425 ·Status: COMPLETED ·Phase: NA
-
BMD Alterations and Bone and Muscle Parameters During Menstrual Cessation With GnRH
NCT04203212 ·Status: COMPLETED
-
Surgery and ART For Endometrioma
NCT03717870 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Endometrial Heparin-binding Epidermal Growth Factor Expression
NCT04175002 ·Status: UNKNOWN
-
Anastrazole Plus GnRH-agonist in the Treatment of Endometriosis Recurrence
NCT01769781 ·Status: COMPLETED ·Phase: PHASE4
-
Preoperative Staging of Endometriosis With MRI
NCT01939535 ·Status: COMPLETED
-
PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata
NCT01156857 ·Status: COMPLETED ·Phase: PHASE3
-
Galectin-3 in Patients With Endometriosis
NCT03212612 ·Status: UNKNOWN
-
Endometriosis and Risk of Obstetric Complications
NCT03354793 ·Status: COMPLETED
-
Research on the Impact of Chronic Pelvic Pain on Endometriosis
NCT06584760 ·Status: NOT_YET_RECRUITING
-
A Study Evaluating the Diagnostic Performance of OCS in the Differential Diagnosis of Endometriosis vs. Endometriosis-Associated Ovarian Cancer
NCT07029659 ·Status: NOT_YET_RECRUITING
-
Comparisons of the Therapeutic Effects of Dienogest and Danazol on Endometriosis
NCT05697471 ·Status: RECRUITING ·Phase: PHASE3
-
The Effect of Neoadjuvant DMPA on Glandular Cellularity in Women Awaiting Hysterectomy
NCT02335203 ·Status: UNKNOWN ·Phase: PHASE2
-
Observational Study of Dydrogesterone in Cycle Regularization
NCT02029144 ·Status: COMPLETED
-
Functional Brain Imaging and Psychological Testing in Women With Chronic Pelvic Pain
NCT02160483 ·Status: WITHDRAWN ·Phase: NA
-
Prognostic Role of molEcular classiFication in Fertility-sparing treAtment of Endometrial canCEr
NCT06799624 ·Status: NOT_YET_RECRUITING
-
Endometrioma Per se Versus Treatment Related Reduction in Ovarian Reserve (ERROR-2 Trial)
NCT03620838 ·Status: UNKNOWN